Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: A prospective, observational, cohort study

Journal of Critical Care

Volumn 30, Issue 1, 2015, Pages 218.e7-218.e12

  Anand, Dimple ^a   Das, Sabari ^a   Bhargava, Seema ^a   Srivastava, Lalit Mohan ^a   Garg, Ashish ^a   Tyagi, Niraj ^a   Taneja, Saurabh ^a   Ray, Sumit ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

Culture negative; Interleukin 6 (IL 6); Negative predictive value (NPV); Procalcitonin (PCT); Sepsis; Systemic inflammatory response syndrome (SIRS)

Indexed keywords

INTERLEUKIN 6; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ABDOMINAL INFECTION; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BLOOD CULTURE; BLOODSTREAM INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; ENDOTRACHEAL CULTURE; FEMALE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT INFECTION; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINE CULTURE; VAGINAL SWAB CULTURE; ADOLESCENT; AREA UNDER THE CURVE; BLOOD; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; INTENSIVE CARE UNIT; MICROBIOLOGY; MIDDLE AGED; SEPSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BACTEREMIA; BIOLOGICAL MARKERS; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 84920610652     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.08.017     Document Type: Article

References (36)

1. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
2. Engel C., Brunkhorst F.M., Bone H.G., Brunkhorst R., Gerlach H., Grond S., et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 2007, 33:606-618.
3. Blanco J., Muriel-Bombín A., Sagredo V., Taboada F., Gandía F., Tamayo L., et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008, 12:R158.
4. Hall M.J., Williams S.N., DeFrances C.J., Golosinskiy A. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS Data Brief 2011, 62:1-8.
5. Dombrovskiy V.Y., Martin A.A., Sunderram J., Paz H.L. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007, 35:1244-1250.
6. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M., Sibbald W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
7. Peres Bota D., Lopes Ferreira F., Melot C., Vincent J.L. Body temperature alterations in the critically ill. Intensive Care Med 2004, 30:811-816.
8. Oberhoffer M., Vogelsang H., Russwurm S., Hartung T., Reinkart K. Outcome prediction by traditional and new markers of inflammation with sepsis. Clin Chem Lab Med 1999, 37:363-368.
9. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353.
10. Vincent J.L., Rello J., Marshall J., Silva E., Anzueto A., Martin C.D., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302:2323-2329.
11. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637.
12. Kumar A., Roberts D., Wood K.E., Light B., Parrillo J.E., Sharma S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
13. Wenzel R.P., Edmond M.B. Managing antibiotic resistance. N Engl J Med 2000, 343:1961-1963.
14. Al-Nawas B., Krammer I., Shah P.M. Procalcitonin serum concentrations and severeity of sepsis. Eur J Med Res 1996, 1:331-333.
15. Hack C.E., De Groot E.R., Felt-Bersma R.J., Nuijens J.H., Strack Van Schijndel R.J., Eerenberg-Belmer A.J., et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989, 74:1704-1710.
16. Anand D., Das S., Ray S., Bhargava S., Srivastava L.M. Interrelationship between procalcitonin and organ failure in sepsis. IJCB 2014, 29:93-96.
17. Tsalik E.L., Jaggers L.B., Glickman S.W., Langley R.J., van Velkinburgh J.C., Park L.P., et al. Discriminative value of inflammatory biomarkers for suspected sepsis. J Emerg Med 2012, 43:97-106.
18. Liaudat S., Dayer E., Praz G., Bille J., Troillet N. Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001, 20:524-527.
19. Chirouze C., Schuhmacher H., Rabaud C., Gil H., Khayat N., Estavoyer J.M., et al. Low serum procalcitonin concentration level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002, 35:156-161.
20. Tang B.M., Eslick G.D., Craig J.C., McLean A.S. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217.
21. Uzzan B., Cohen R., Nicolas P., Cucherat M., Perret G.Y. Procalcitonin as a diagnostic test for sepsis in critically ill adults after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34:1996-2003.
22. Wacker C., Prkno A., Brunkhorst F.M., Schlattmann Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013, 13:426-435.
23. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
24. Youden W.J. Index for rating diagnostic tests. Cancer 1950, 3:32-35.
25. Brunkhorst F.M., Wegscheider K., Forycki Z.F., Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, severe sepsis and septic shock. Intensive Care Med 2000, 26:148-152.
26. Harbarth S., Holeckova K., Froidevaux C., Pittet D., Ricou B., Grau G.E., et al. Diagnostic value of procalcitonin, interleukin-6 and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164:396-402.
27. Le Moullec J.M., Jullienne A., Chenais J., Lasmoles F., Guliana J.M., Milhaud G., Moukhtar M.S. The complete sequence of human preprocalcitonin. FEBS 1984, 167:93-97.
28. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341:515-518.
29. Dandona P., Nix D., Wilson M.F., Aljada A., Love J., Assicot M., Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994, 79:1605-1608.
30. Fioretto J.R., Martin J.G., Kurokawa C.S., Carpi M.F., Bonatto R.C., Ricchetti S.M., de Moraes M.A., Padovani C.R. Interleukin-6 and procalcitonin in children with sepsis and septic shock. Cytokine 2008, 43:160-164.
31. Phua J., Ngerng W.J., See K.C., Tay C.K., Kiong T., Lim H.F., et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care 2013, 17:R202.
32. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
33. Meynaar I.A., Droog W., Batstra M., Vreede R., Herbrink P. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6 or LBP. Crit Care Res Pract 2011, 2011:594-645.
34. Naffaa M., Makhoul B.F., Tobia A., Kaplan M., Aronson D., Azzam Z.S., Saliba W. Procalcitonin and interleukin-6 for predicting blood culture positivity in sepsis. Am J Emerg Med 2014, 32:448-451.
35. Mimoz O., Benoist J.F., Edouard A.R., Assicot M., Bohoun C., Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998, 24:185-188.
36. Reinhart K., Bauer M., Riedemann N.C., Hatoq C.S. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 2012, 25:609-634.